Background: Frailty is a multifactorial syndrome associated with adverse health outcomes. The metabolic underpinnings of frailty, particularly lipid metabolism, are not fully understood. Unlike isolated lipid fractions or inflammatory markers, atherogenic index of plasma (AIP) integrates atherogenic lipid profiles and systemic inflammation. However, its association with frailty has not been extensively studied.
Methods: Six thousand four hundred participants from the National Health and Nutrition Examination Survey (NHANES) were enrolled. Frailty was calculated with the frailty index (FI), with scores ≥ 0.21 indicating frailty. Logistic regression adjusted for demographic, socioeconomic, and lifestyle factors evaluated the association between AIP and frailty. Restricted cubic splines (RCS) explored nonlinear associations, and subgroup analyses assessed interactions across age, sex, race, poverty income ratio, smoking status, drinking status, and marital status.
Results: This study demonstrated a strong dose-response relationship between AIP and frailty. After full adjustment, Individuals in quartile 3 and 4 showed higher odds of frailty than those in lowest quartile, with ORs (95% CI) of 1.26(1.01,1.57) and 1.73(1.34,2.23), respectively. Continuous AIP measures also exhibited significant associations (OR: 1.82, 95% CI: 1.34-2.47). RCS analysis showed that AIP exhibited a nonlinear association with the risk of frailty. Subgroup analyses showed the associations were more pronounced in the females. The sensitivity analyses substantiated the stability and strength of the results.
Conclusions: Our findings suggest that elevated AIP levels are independently associated with frailty risk, particularly in females, highlighting its potential as a cost-effective biomarker for risk stratification. Future longitudinal studies are needed to validate AIP's predictive utility and uncover the underlying mechanisms.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11884020 | PMC |
http://dx.doi.org/10.1186/s12944-025-02504-x | DOI Listing |
J Frailty Aging
March 2025
Department of Community Medicine, VMMC and Safdarjung Hospital, New Delhi 110029, India. Electronic address:
Frailty, a biologic syndrome of decreased reserve and resistance to stressors, affects 5 % to 17 % of older adults and is linked to factors like low BMI, female sex, and low exercise levels. With India's older population expected to double by 2050, frailty presents major public health and economic challenges. This study summarizes the prevalence of frailty among community-dwelling Indians.
View Article and Find Full Text PDFCurr Opin Clin Nutr Metab Care
March 2025
Division of Human Nutrition and Health, Wageningen University & Research, Wageningen.
Purpose Of Review: Sarcopenia and frailty are common conditions, associated with worse clinical outcomes during critical illness. Recent studies on sarcopenia and frailty in ICU patients are presented in this review, aiming to identify accurate diagnostic tools, investigate the effects on clinical and functional outcomes, and propose possible effective interventions.
Recent Findings: The recent change of the sarcopenia definition underlines the importance of muscle strength over mass, this is however challenging to assess in ICU patients.
JAMA Netw Open
March 2025
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill.
Importance: Frailty assessed at a single time point is associated with mortality in older women with breast cancer. Little is known about how changes in frailty following cancer treatment initiation affect mortality.
Objective: To evaluate the association between claims-based frailty trajectories following adjuvant chemotherapy initiation and 5-year mortality in older women with stage I to III breast cancer.
Ann Emerg Med
March 2025
Department of Emergency Medicine, Mayo Clinic, Rochester, MN; Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN. Electronic address:
Study Objective: To compare 30-day mortality and return emergency department (ED) visits among older adults with delirium who are discharged home with those discharged home without delirium and those who are admitted to the hospital with and without delirium.
Methods: Adults aged 75 and older years were assessed for delirium using the Delirium Triage Screen followed by the Brief Confusion Assessment Method. We evaluated outcomes including return visits and 30-day mortality.
J Am Geriatr Soc
March 2025
McGill University Health Centre, McGill University, Montreal, Canada.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!